Literature DB >> 6322952

Bilateral breast cancer in northern Alberta: risk factors and survival patterns.

P E Burns, K Dabbs, C May, A W Lees, L R Birkett, H J Jenkins, J Hanson.   

Abstract

Of 2231 women with stage I, II or III breast cancer who were registered and seen between 1971 and 1979 and followed to the end of 1981, 48 (2.2%) had synchronous and 58 (2.6%) asynchronous bilateral breast cancer. The unadjusted incidence rate for a second breast cancer was 6.4/1000 breast-years at risk, compared with a rate of 0.70 for the risk of a first breast cancer in women. When calculated from the date of diagnosis of the first breast cancer the survival rate was better for the group with asynchronous disease than for the group with synchronous disease or for a group with unilateral disease, but when calculated from the date of diagnosis of the second cancer the rate was the same in all three groups. Comparison of known risk factors showed a significant association between the development of bilateral cancer and a later age at the birth of the first child and a longer interval between menarche and that birth. There was a trend towards greater age and more stage III cancer in the group with synchronous disease. There was no correlation between receiving radiotherapy for the first breast cancer and development of the second cancer. Annual mammography and clinical examination of asymptomatic women at a cancer centre resulted in the detection of a significantly higher proportion of minimal breast cancers in the second breast compared with the first. Such screening practices should be even more valuable in the earlier detection of unilateral breast cancer in asymptomatic women who have not had breast cancer.

Entities:  

Mesh:

Year:  1984        PMID: 6322952      PMCID: PMC1875971     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  22 in total

1.  Relative accuracy of clinical examination and mammography in a breast clinic in Alberta.

Authors:  P E Burns; C May; Z Gutter; H A Ferri; M Grace
Journal:  J Can Assoc Radiol       Date:  1978-03

2.  Bilateral breast cancer: biopsy of the opposite breast.

Authors:  J A Urban; D Papachristou; J Taylor
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

3.  Breast Cancer Detection Demonstration Project: five-year summary report.

Authors:  L H Baker
Journal:  CA Cancer J Clin       Date:  1982 Jul-Aug       Impact factor: 508.702

4.  Characteristics of familial breast cancer in Sweden: absence of relation to age and unilateral versus bilateral disease.

Authors:  H O Adami; J Hansen; B Jung; A Rimsten
Journal:  Cancer       Date:  1981-10-01       Impact factor: 6.860

5.  The developmental pathology of breast cancer.

Authors:  H S Gallager
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

6.  Breast cancer in northern Alberta: pilot study in computerized registration.

Authors:  P E Burns; J Kredentser; M Grace; J Hanson
Journal:  Can Med Assoc J       Date:  1977-05-21       Impact factor: 8.262

Review 7.  Lobular carcinoma of the breast: an overview.

Authors:  E R Fisher; B Fisher
Journal:  Ann Surg       Date:  1977-04       Impact factor: 12.969

8.  Factors influencing survival in bilateral breast cancer.

Authors:  A S Al-Jurf; P R Jochimsen; L F Urdaneta; D H Scott
Journal:  J Surg Oncol       Date:  1981       Impact factor: 3.454

9.  Bilateral breast cancer in patients with initial stage I and II disease.

Authors:  S R Schell; E D Montague; W J Spanos; N D Tapley; G H Fletcher; M J Oswald
Journal:  Cancer       Date:  1982-09-15       Impact factor: 6.860

10.  Bilateral breast cancer at the Johns Hopkins Hospital. A discussion of the dilemma of contralateral breast cancer.

Authors:  E F Lewison; A S Neto
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

View more
  9 in total

1.  Bilateral breast cancer: one disease or two?

Authors:  P J Dawson; T Maloney; P Gimotty; P Juneau; H Ownby; S R Wolman
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

2.  Risk factors and 10-year breast cancer survival in northern Alberta.

Authors:  A W Lees; H J Jenkins; C L May; G Cherian; E W Lam; J Hanson
Journal:  Breast Cancer Res Treat       Date:  1989-03       Impact factor: 4.872

3.  Bilateral breast cancer following augmentation mammaplasty with polyacrylamide hydrogel injection: A case report.

Authors:  Yaning Zhao; N A Yuan; Kuanzhi Li; Y I Geng; Haiping Zhou; Hua Wang; Jie Hou; Bin Zhang; Yuan Cai; Xinhan Zhao
Journal:  Oncol Lett       Date:  2015-04-14       Impact factor: 2.967

4.  Bilateral breast cancer. Risk reduction by contralateral biopsy.

Authors:  H J Wanebo; G M Senofsky; R E Fechner; D Kaiser; S Lynn; J Paradies
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

5.  A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)

Authors:  L S Cook; E White; S M Schwartz; B McKnight; J R Daling; N S Weiss
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

6.  Prediction of outcome after diagnosis of metachronous contralateral breast cancer.

Authors:  Sara Alkner; Pär-Ola Bendahl; Mårten Fernö; Jonas Manjer; Lisa Rydén
Journal:  BMC Cancer       Date:  2011-03-30       Impact factor: 4.430

7.  Comparison of the histopathology and prognosis of bilateral versus unilateral multifocal multicentric breast cancers.

Authors:  Hüseyin Kadioğlu; Serdar Özbaş; Alper Akcan; Aykut Soyder; Lutfi Soylu; Savaş Koçak; N Zafer Cantürk; Mustafa Tükenmez; Mahmut Müslümanoğlu
Journal:  World J Surg Oncol       Date:  2014-08-20       Impact factor: 2.754

8.  Prognosis in bilateral breast cancer. Effects of time interval between first and second primary tumours.

Authors:  L Holmberg; H O Adami; A Ekbom; R Bergström; A Sandström; A Lindgren
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

9.  A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors.

Authors:  Jia-Jian Chen; Yan Wang; Jing-Yan Xue; Ying Chen; Ya-Ling Chen; Qin Xiao; Wen-Tao Yang; Zhi-Min Shao; Jiong Wu
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.